MedTrace Logo

Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.

NCT04396015 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-05-20

No results posted yet for this study

Summary

The present study is being done in a scientifically rigorous manner, using readily available MCT oil (refined from coconut oil) versus a placebo oil to assess any cognitive and functional benefits for AD patients.

Conditions

  • Cognitive Function 1, Social

Interventions

DIETARY_SUPPLEMENT

Bulletproof Brain Octane

Medium chain triglyceride oil (MCT)

DIETARY_SUPPLEMENT

Placebo

Placebo (olive) oil

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-01-31
Completion
2019-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396015 on ClinicalTrials.gov